Eko Health has been advancing the use of artificial intelligence to help providers detect the early signs of disease, ...

Researchers developed a new COPD-ES questionnaire for healthcare professionals to improve the management of stable chronic ...

Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team ...

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

Medical experts and death row inmates file legal briefs challenging legality of Arizona's execution drugs ahead of March ...

GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around ...

The global drug delivery solutions market is poised for significant growth, with an estimated value of USD 113.3 million in ...

Sales of Eylea, which the company co-developed with Bayer (DE:BAYA), rose 2% to $1.495 billion. Sales of the higher-dose, longer-lasting formulation Eylea HD rose 148% to $305 million in the U.S., ...

Columnist Caroline Gainer has been sleeping a lot more than usual lately, so she investigates whether that's normal for ...

Injurious falls are common among people with COPD in the 2 years before death, with some medications tied to higher fall risk.

FDA approved bronchodilator carmoterol and d-methamphetamine found in 23 drug tests from horses running at Lone Star Park ...

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...